Ausgabe 3/2008
Inhalt (18 Artikel)
An overview of prognostic factors for long-term survivors of breast cancer
Isabelle Soerjomataram, Marieke W. J. Louwman, Jacques G. Ribot, Jan A. Roukema, Jan Willem W. Coebergh
Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer
Sebastian Aulmann, Roland Penzel, Thomas Longerich, Benjamin Funke, Peter Schirmacher, Hans Peter Sinn
Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility
Karin Milde-Langosch, Stanislava Janke, Ines Wagner, Christine Schröder, Thomas Streichert, Ana-Maria Bamberger, Fritz Jänicke, Thomas Löning
Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIPL
Natalya V. Guseva, Oskar W. Rokhlin, Agshin F. Taghiyev, Michael B. Cohen
Inhibition of mammary tumorigenesis in the C3(1)/SV40 mouse model by green tea
Hoyee Leong, Priya S. Mathur, Geoffrey L. Greene
Risk of neoplastic transformation in asymptomatic radial scar. Analysis of 117 cases
Erminia Manfrin, Andrea Remo, Francesca Falsirollo, Daniela Reghellin, Franco Bonetti
Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy
Ou Huang, Liping Wang, Kunwei Shen, Hong Lin, Zhen Hu, Guangyu Liu, Jiong Wu, Jinsong Lu, Zhiming Shao, Qixia Han, Zhenzhou Shen
Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations
H. M. Verkooijen, V. C. M. Koot, G. Fioretta, M. van der Heiden, M. E. I. Schipper, E. Rapiti, P. H. M. Peeters, J. L. Peterse, C. Bouchardy
Diffusion of aromatase inhibitors for breast cancer therapy between 1996 and 2003 in the Cancer Research Network
Erin J. Aiello, Diana S. M. Buist, Edward H. Wagner, Leah Tuzzio, Sarah M. Greene, Lois E. Lamerato, Terry S. Field, Lisa J. Herrinton, Reina Haque, Gene Hart, Kimberly J. Bischoff, Ann M. Geiger
Advanced stages and poorly differentiated grade are associated with an increased risk of HER2/neu positive breast carcinoma only in White women: findings from a prospective cohort study of African-American and White-American women
Azadeh Stark, Alissa Kapke, Daniel Schultz, Ron Brown, Michael Linden, Usha Raju
Estrogen receptor α polymorphisms and postmenopausal breast cancer risk
A. M. González-Zuloeta Ladd, A. Arias Vásquez, F. Rivadeneira, C. Siemes, A. Hofman, B. H. Ch. Stricker, H. A. P. Pols, A. G. Uitterlinden, C. M. van Duijn
Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk
Yong Zhu, Richard G. Stevens, Derek Leaderer, Aaron Hoffman, Theodore Holford, Yawei Zhang, Heather N. Brown, Tongzhang Zheng
Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy
Alexander Katalinic, Rajesh Rawal
Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients
Irene Konstantopoulou, Theodore Rampias, Angela Ladopoulou, George Koutsodontis, Sophia Armaou, Theodore Anagnostopoulos, George Nikolopoulos, Smaragda Kamakari, George Nounesis, Antonis Stylianakis, Charisios Karanikiotis, Evangelia Razis, Helen Gogas, Antonios Keramopoulos, Vassiliki Gaki, Christos Markopoulos, Dimosthenis Skarlos, Nikos Pandis, Thalia Bei, Iordanis Arzimanoglou, George Fountzilas, Drakoulis Yannoukakos
The development of a predictive model to estimate cardiotoxic risk for patients with metastatic breast cancer receiving anthracyclines
George Dranitsaris, Daniel Rayson, Mark Vincent, Jose Chang, Karen Gelmon, David Sandor, Greg Reardon
Cardiotoxicity and anthracyclines
Justin Stebbing, Alison Jones, Peter Barrett-Lee
Detection of the CHEK2 1100delC mutation by MLPA BRCA1/2 analysis: a worthwhile strategy for its clinical applicability in 1100delC low-frequency populations?
Sara Gutiérrez-Enríquez, Judith Balmaña, Montserrat Baiget, Orland Díez
Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case–control study and a pooled meta-analysis
Tanja Langsenlehner, Wilfried Renner, Babak Yazdani-Biuki, Uwe Langsenlehner